Dr. Robert A. Curtis Pharm.D. serves as Independent Director of the Company. Dr. Curtis is a 35-year veteran in the biosciences industry. Dr. Curtis currently serves as a consultant to emerging technology companies. He recently served as the Executive Chairman and Director of the Trudeau Institute in Saranac Lake, New York and prior to that position he was Chief Executive Officer (CEO) of the Regional Technology Development Corporation, a non-profit organization in Woods Hole, Massachusetts, where he was responsible for identifying and commercializing technology from the Marine Biological Laboratory and the Woods Hole Oceanographic Institute. Dr. Curtis has been a founder and CEO of several companies, including HistoRx, Inc, a tissue proteomics company, Cape Aquaculture Technologies, Inc. which developed enhanced non-genetically modified fish, Lion Pharmaceuticals/Phoenix Drug Discovery LLC, a novel business model to develop and commercialize university-based technology from some of the leading biomedical institutions in the world. He assisted in the founding of Environmental Operating Solutions, Inc, which applied denitrification technology to wastewater with the company being sold in 2017. He was a co-founder of and CEO of CombiChem, Inc., which was purchased by Dupont Pharmaceuticals, and served as founding President and CEO of MetaMorphix, Inc., a joint venture between Genetics Institute, Inc. and The Johns Hopkins School of Medicine. Prior to these entrepreneurial endeavors, Dr. Curtis held senior management positions at Practice at the University of Illinois Medical Center in Chicago. He currently serves on the board or as an advisor to a number of private entrepreneurial companies and has served as judge for the annual MIT $100K Business Plan Entrepreneurial Award. He is Chairman of Fundraising for the Falmouth Commodores of the Cape Cod Baseball League. Dr. Curtis holds a BS in Pharmacy from the Massachusetts College of Pharmacy, a Pharm.D. from the University of Missouri, and an MBA from Columbia Univers
Robert Curtis is 65, he's been the Independent Director of Nxt-ID Inc since 2018. There are 1 older and 8 younger executives at Nxt-ID Inc. The oldest executive at Nxt-ID Inc is David Gust, 77, who is the Independent Director.
Robert's mailing address filed with the SEC is 2801 DIODE LANE, , LOUISVILLE, KY, 40299.
Over the last 11 years, insiders at Nxt-ID Inc have traded over $400,900 worth of Nxt-ID Inc stock and bought 4,302 units worth $8,894 . The most active insiders traders include Gino Miguel Pereira, C. David Tunnell a Michael Joseph Orlando. On average, Nxt-ID Inc executives and independent directors trade stock every 19 days with the average trade being worth of $52,698. The most recent stock trade was executed by Michael Joseph Orlando on 13 November 2018, trading 10,000 units of NXTD stock currently worth $11,000.
Nxt-ID, Inc. provides technology products and services for healthcare applications. The Company has extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization and sensor technologies. Through its subsidiary, LogicMark LLC, Nxt-ID, Inc. is a manufacturer and distributor of non-monitored and monitored personal emergency response systems sold through dealers/distributors and the United States Department of Veterans Affairs.
Nxt-ID Inc executives and other stock owners filed with the SEC include: